Bromocriptin and rheumatoid arthritis
Not Applicable
- Conditions
- Rheumatoid arthritis.Seropositive rheumatoid arthritis
- Registration Number
- IRCT201008121778N3
- Lead Sponsor
- Vice chancellor of research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Rheumatoid arthritis patients (proved by ACR criteria) that greater than 16 years old with active R.A (DAS>4) despite conventional thrapy.
Exclusion criteria: Drug reaction, lapse from the study, Immigration or death, containdications for bromocriptin
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical and laboratory findings. Timepoint: Before the study and 3 months later. Method of measurement: DAS28, ESR, VAS, Prolactin.
- Secondary Outcome Measures
Name Time Method